We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Euromedlab Congress 2021 Postponed as Fourth COVID-19 Wave Hits Germany

By LabMedica International staff writers
Posted on 24 Nov 2021
Print article
Illustration
Illustration

The XXIV IFCCEFLM European Congress of Clinical Chemistry and Laboratory Medicine (EuroMedLab Congress 2021) to be held as an in-presence meeting between 28th of November and 2nd of December in Germany has been postponed as the country has been hit very hard by a fourth wave of COVID-19.

The biannual EuroMedLab congress is jointly hosted by the International Federation of Clinical Chemistry and Laboratory Medicine (IFCC; Lombardia, Italy), European Federation of Clinical Chemistry and Laboratory Medicine (EFLM; Milano, Italy), and the German Society for Clinical Chemistry and Laboratory Medicine (DGKL; Berlin, Germany). The event has proven to be one of the leading forums to bring together scientists, laboratory specialists, clinicians, and industry colleagues in the field of clinical chemistry and laboratory medicine.

The 24th EuroMedLab would have been the first major IFCC/EFLM conference to be held following a long delay caused by the pandemic and was expected to provide an excellent opportunity to bring together laboratory specialists from many national societies both physically and virtually. At EuroMedLab Congress 2021, attendees were expected to experience the outstanding scientific program, featuring innovative and diverse educational opportunities that incorporate the best of clinical laboratory medicine and in vitro diagnostics, including lectures, symposia, recent advancements in clinical practice and science, poster presentations, and much more. In addition to the scientific program, excellent social opportunities had been organized for the attendees to enjoy many attractions in Munich.

However, at a time when the EuroMedLab Congress 2021 was in the final stages of preparation, Germany has been hit very hard by a fourth COVID-19 wave, particularly in the area of the venue in Munich. Travel warnings for Germany have been issued by some countries even for vaccinated individuals, making it potentially problematic to return home after the congress. The local government has announced lockdowns for the coming days in all areas, where the seven-day incidences exceed 1,000 in 100,000. Munich as the EuroMedLab venue is approaching this threshold. Keeping in mind the safety of all attendees, exhibitors and staff, the organizers have decided that an orderly meeting cannot be warranted under these conditions. Therefore, IFCC and EFLM, together with the Congress Organizing Committee have decided to postpone EuroMedLab Congress 2021. The organizers are currently looking into rescheduling in 2022 and will communicate a new date for the conference in the near future.

Related Links:
IFCC 
EFLM 
DGKL

Gold Member
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Amoebiasis Test
ELI.H.A Amoeba
New
FOB+Transferrin+Calprotectin+Lactoferrin Test
CerTest FOB+Transferrin+Calprotectin+Lactoferrin Combo Test

Print article

Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.